+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Closed System Transfer Devices (CSTD) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 100 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4986970

Limiting the exposure of hazardous drugs/chemicals is important due to the potential harm that might cause to the healthcare workers and patients in healthcare/clinical setups. Due to the increased incidence of hazardous drug exposures in many countries, the regulatory authorities have taken many initiatives to ensure the safety of patients and healthcare workers. Owing to the factors such as growing awareness regarding usage of closed system transfer devices and increased oncology drug approvals global closed system transfer devices (CSTD) market is expected to witness CAGR of 18% over the forecast period. Furthermore, increasing prevalence of cancer and technological advancements in the closed system transfer devices anticipated to boost the market growth. The High cost involved in the implementation of closed system transfer devices directly increases the cost of treatment/products. Furthermore, improper regulatory guidelines in developing and underdeveloped countries may hamper market growth over the forecast period. However, developments in CSTD technologies making devices more user-friendly and safer than the older devices.

Key Market Trends

Membrane to Membrane Transfer Devices Anticipated to Grow at Significant Rates

Membrane to membrane transfer devices use the double membrane system between the vial and syringe further helps to isolate the medication. The advantages such as ease of use, low risk of contamination and double-membrane systems ensure the safety anticipated to increase the usage of the membrane to membrane transfer devices over the forecast period. Needleless system segment is anticipated to grow at notable rates owing to the advantages such as needle-free transfer of the medication, new product launches and safety. For instance, in January 2018, Baxter International has launched Yukon Medical, LLC’s Airsure closed system transfer device in the United States to prevent contaminants to enter into an IV medication delivery system.

Moreover, the growing incidence of cancer cases and awareness regarding the usage of closed system transfer devices anticipated to fuel the market growth.

North America Expected to have Significant Market Share

North America is expected to have a significant market share in closed system transfer devices market. The growth is attributed to initiatives taken by the U.S. Food and Drug Administration and other regulatory bodies in North America to ensure patient safety coupled with the increasing number of oncology drug approvals in the region. The Asia Pacific region is projected to have the notable growth rate owing to the factors such as the increase in cancer research, growing prevalence of cancer in developing and underdeveloped countries of the region. Furthermore, the usage of the closed system transfer devices to combat the hazardous drugs in the region and continuous efforts by the public and private organizations anticipated to boost the regional growth.

Competitive Landscape

Global transfer membrane market is moderately consolidated and competitive. Market players are focusing on new product launches, product innovations and geographical expansion. The key market players operating in the market include Becton, Dickinson and Company, ICU Medical, Inc., Caragen Ltd., Baxter International Inc. and B. Braun Melsungen AG among others

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cancer and increasing Oncology Drug Approvals
4.2.2 Advancements in Technologies and Improving Regulatory Guidelines
4.3 Market Restraints
4.3.1 High Cost for Closed System Transfer Device Implementation
4.3.2 Lack of Proper Regulatory Guidelines In Many of the Countries
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 Needless Systems
5.1.2 Membrane to Membrane Systems
5.2 By Closing Mechanism
5.2.1 Colour to Colour Alignment Systems
5.2.2 Lueker Lock Systems
5.2.3 Push to Turn systems
5.2.4 Click to Lock Systems
5.3 By Component
5.3.1 Syringe Safety Devices
5.3.2 Vial Access Devices
5.3.3 Bag Access Devices
5.3.4 Others
5.4 By Technology
5.4.1 Compartmentalize Devices
5.4.2 Diaphragm Based Devices
5.4.3 Air Filtration Devices
5.5 By End-Use
5.5.1 Hospitals
5.5.2 Oncology Clinics and Oncology Centers
5.5.3 Others
5.6 Geography
5.6.1 North America United States Canada Mexico
5.6.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.6.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.6.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.6.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Caragen Ltd
6.1.3 Baxter International Inc.
6.1.4 B. Braun Melsungen AG
6.1.5 ICU Medical, Inc.
6.1.6 Corvida Medical
6.1.7 JMS CO., LTD.
6.1.8 Equashield, LLC
6.1.9 Yukon Medical, LLC

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton, Dickinson and Company
  • Caragen Ltd
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • Corvida Medical
  • JMS CO., LTD.
  • Equashield, LLC
  • Yukon Medical, LLC